The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-11. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | computed for the free peptide |
| Molecular weight | about 1419 Da | monoisotopic mass near 1418.7 |
| Amino acid count | 15 | single chain, no disulfide bonds |
| Solubility | freely soluble in water | also dissolves in saline and phosphate buffer |
| Common synonyms | pentadecapeptide BPC, BPC 157 | fragment notation varies by source |
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
John Herbert resigned from Parliament on 13 September 1978 due to terminally ill health. Sam Doumany was appointed to replace him in the cabinet and as Minister for Welfare on 2 October 1978. On 9 October 1978, Llew Edwards replaced William Knox as leader of the Liberal Party and hence Deputy Premier of Queensland. On 15 December 1978, they swapped portfolios, with Knox becoming Minister for Health and Edwards becoming Treasurer. On 31 July 1979, Max Hodges resigned from Parliament, and on 21 August 1978, Tom Newbery resigned from the ministry. Max Hooper and Ivan Gibbs were appointed to replace them in cabinet and in their roles on 24 August 1978. On 17 August 1980, Ron Camm resigned from Parliament to become chairman of the Sugar Board. Russ Hinze and Vic Sullivan added his cabinet roles to their responsibilities, while Mike Ahern was appointed to the cabinet vacancy.
=== Bibliography === Hamburg Institute for Social Research, ed. (1999). The German Army and Genocide: Crimes Against War Prisoners, Jews, and Other Civilians in the East, 1939-1944. New York: New Press. ISBN 978-1-56584-525-1. Jentz, Thomas (1996). Panzertruppen Vol. 2 The Complete Guide to the Creation & Combat Employment of Germany's Tank Force 1943-1945. Atglen, PA: Schiffer Publishing. ISBN 0-7643-0080-6. Nafziger, George. "Organizational History of Miscelleanous German Named Infantry and Panzer Grenadier, Brigades, Verbands & Divisions, 1939-1945" (PDF). Combined Arms Research Library Digital Library. US Army Combined Arms Center. Retrieved 10 July 2016. Scheibert, Horst (1987). Culver, Bruce (ed.). Panzer Grenadier Division Grossdeutschland: A Pictorial History with Text & Maps. Translated by Gisele Hockenberry. Carrollton, Texas: Squadron/Signal Publications. ISBN 0-89747-061-3. Sharpe, Michael & Davis, Brian L (2001). Grossdeutschland: Guderian's Eastern Front Elite. Compendium Publishing. ISBN 0-7110-2854-0. Solarz, Jacek (2005). Division/Korps Großdeutschland 1943-1945. Vol. I and II. Warsaw: Wydawnictwo Militaria. ISBN 83-7219-237-5. Spaeter, Helmuth (1992). The History of the Panzerkorps Großdeutschland Vol I. Winnipeg, Canada: J. J. Fedorowicz Publishing. ISBN 0-921991-12-6. Spaeter, Helmuth (1995). The History of the Panzerkorps Großdeutschland Vol II. Winnipeg, Canada: J. J. Fedorowicz Publishing. ISBN 0-921991-27-4. Spaeter, Helmuth (2000). The History of the Panzerkorps Großdeutschland Vol III. Winnipeg, Canada: J. J. Fedorowicz Publishing.
Escherichia coli infections, Klebsiella aerogenes infections, Shigella species infections, Acinetobacter species infections, respiratory tract infections caused by Haemophilus influenzae, respiratory tract and urinary tract infections caused by Klebsiella species.
Sources: en.wikipedia.org
== Diagnosis == No specific test exists to diagnose polymyalgia rheumatica; many other diseases can cause inflammation and pain in muscles, but a few tests can help narrow down the cause of the pain. Limitation in shoulder motion or swelling of the joints in the wrists or hands, are noted by the doctor. One blood test usually performed is the erythrocyte sedimentation rate (ESR) which measures how fast the patient's red blood cells settle in a test tube. The faster the red blood cells settle, the higher the ESR value (measured in mm/hour), which suggests that inflammation may be present. Many conditions can cause an elevated ESR, so this test alone is not proof that a person has polymyalgia rheumatica. Another test that checks the level of C-reactive protein (CRP) in the blood may also be conducted. CRP is produced by the liver in response to an injury or infection, and people with polymyalgia rheumatica usually have high levels. However, like the ESR, this test is also not very specific. Polymyalgia rheumatica is sometimes associated with temporal arteritis, a condition requiring more aggressive therapy. To test for this additional disorder, a biopsy sample may be taken from the temporal artery.
== Description == The cap ranges from 5–15 centimetres (2–6 in) in width and is usually yellow with brownish areas, particularly at the centre. The skin layer covering the cap is sticky and can be peeled off. The yellow stem is 4–10 cm long and 1–2 cm wide, and brownish at the base. The gills are also yellow and the spores are white, producing a white spore print.
Pakistani military claimed to have killed 34 TTP militants in engagement throughout Khyber Pakhtunkhwa and Balochistan, with three killed in Lakki Marwat district, 10 killed in Bannu district and 13 killed in North Waziristan as well as eight killed in Zhob district. A police constable was killed in a militant attack in Wana while six police personnel including a DSP were killed and three were wounded in an insurgent ambush in Kohat District. An ex-Police officer and a militant were killed while another militant was injured in an engagement in Peshawar District. On 25 February, local sources reported that further skirmishes took place in Maqbal area in Dand Aw Patan District of Paktia province between Taliban and Pakistani forces. Light clashes took place in Mohmand and Kurram Districts whereas heavy fighting occurred in Khyber District between Pakistani security forces and Pakistani Taliban. Pakistani military claimed to have killed 10 TTP militants in a follow-up operation in Zhob District. Unidentified militants attacked a police patrol in Bajaur killing four and wounding two police personnel and also killed a constable and his son in South Waziristan. On 26 February, at around 20:00 local time (15:30 GMT), Taliban-led Afghanistan's officials announced the launch of what they described as a "retaliatory operation", directed by Defence Minister Mullah Yaqoob and Army Chief Fasihuddin Fitrat, along the border in the provinces of Nangarhar, Nuristan, Kunar, Khost, Paktia, and Paktika.
== Effectiveness == The American Cancer Society states that "There is little scientific evidence available to support proponents' claims that myofascial release relieves pain or restores flexibility" and cautions against using it as a substitute for conventional cancer treatment. The poor quality of research into the use of myofascial release for orthopaedic conditions precludes any conclusions being drawn about its usefulness for this purpose. In 2011, the UK Advertising Standards Authority (ASA) upheld a complaint about claims of effectiveness made in promotional material by Myofascial Release UK health care service. The ASA Council ruled that materials presented by Myofascial Release UK in support of the claims made in their ad were inadequate to establish a "body of robust scientific evidence" to substantiate Myofascial Release UK's range of claims. In addition, the ASA determined that the ad breached advertising rules by introducing a risk that readers might be discouraged from seeking other essential medical treatments. Reviews published in 2013 and 2015 evaluating evidence for MFR's efficacy found that existing clinical trials varied widely in quality, technique, and outcome measures, yielding mixed results. The 2015 review noted: "it is time for scientific evidences on MFR to support its clinical use." Another review concluded that the use of foam rollers or a roller massager before or after exercise for self-myofascial release has been observed to decrease soreness due to DOMS and that self-myofascial release appears to have no negative effect on performance.
Sources: en.wikipedia.org
== Limitations == Humanized mice present several important limitations that affect their translational value. The reconstitution of the human immune system remains incomplete, particularly for myeloid lineages and fully functional adaptive immune responses, leading to an underrepresentation of key human immune mechanisms. In addition, the murine microenvironment does not fully support human immune cell development, as species-specific differences in cytokine signaling and cellular interactions can alter immune cell maturation and function. Another major limitation is the frequent development of graft-versus-host disease (GVHD), especially in PBMC-based models, which induces systemic inflammation and significantly restricts the duration of experiments, limiting long-term studies. Moreover, these models are costly and technically demanding to establish, requiring specialized procedures such as irradiation, stem cell engraftment, and strict animal facility conditions, which limits their accessibility and scalability. Finally, donor-dependent variability introduces inconsistencies between experiments, reducing reproducibility and complicating the interpretation of results in preclinical studies.
She has also been involved in creating a new zebrafish model to study the role of glutathione S-transferase π1 in development, redox homeostasis, and drug response involving cytotoxicity through endoplasmic reticulum stress and unfolded protein response. Additionally, in an Antioxidants & Redox Signaling review, she analyzed the influence of the S-glutathionylation cycle on protein structure, cellular regulation, and its significance for interventions in stress- and aging-related pathologies. Furthermore, her research has demonstrated that altered GSTP expression within the endoplasmic reticulum regulates protein homeostasis (proteostasis) through S-glutathionylation of ER resident proteins, including PDI and BiP. GSTP leads to S-glutathionylation of binding immunoglobulin protein (BiP), contributing to acquired resistance to Btz in multiple myeloma (MM) cells, representing a novel mechanism of drug resistance in MM. She has also emphasized GSTπ's novel role in enhancing S-glutathionylation reactions under oxidative and nitrosative stress, with implications for stress response and drug resistance in tumors.
This description highlights the partial double bond that exists between the carbonyl carbon and nitrogen, which raises the rotational barrier. Thus, the molecule is not able to freely rotate around its main axis and the (E)-configuration is preferred due to steric repulsion of the larger substituents. This molecule has been tentatively identified in interstellar space by the ALMA radio telescope. It may have formed on dust grains. This could prove to be a key molecule for interstellar pre-biotic chemistry due to its peptide bond.
Sources: en.wikipedia.org
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.
In most jurisdictions it is not an approved medicine and is handled as a research material. Import and sale rules differ by country, and some regulators have placed it in categories that restrict human use. Status can change, so current local rules apply.
Rodent models dominate, particularly rats with induced gastric lesions, tendon injury, or vascular disruption. These designs allow controlled comparison but differ anatomically and metabolically from humans. Results from such models are commonly cited as preliminary.
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.